Alphatec Holdings, Inc. ATEC

Full chart Compare
Set alert

Price alert · ATEC

All alert types
8.28 USD +0.81 (+10.84%)

At closeNov 4, 2026, 5:42 PM EST

8.30 +0.02 +0.24%

After hours · Nov 4, 5:42 PM ET

7.45 Day range 8.34
6.99 52-week range 22.68
YTD
-60.65%
1 year
-57.36%
Market cap
1.27B
Revenue (ttm)
839.72M
Profit margin
-10.35%
EPS (ttm)
-0.63
Shares out
153.33M
Forward P/E
14.70
YTD return
-60.65%
1-year return
-57.36%
Volume
6.98M
Avg volume
2.99M
Open
7.45
Previous close
7.47
Day's range
7.45 – 8.34
52-week range
6.99 – 22.68
Beta
0.87
Analysts
Strong Buy
Price target
13.29 (+60.5%)
Earnings date
Feb 23, 2027

2Y -0.30 (-3.50%)

101520Jan 25Jun 25Nov 25Apr 26Aug 268.28

Key statistics

Enterprise value
1.70B
PEG ratio
0.48
Price / sales
1.51
Price / book
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
12.60%
Free cash flow
29.95M
Total cash
79.94M
Total debt
593.95M
Return on equity
-308.06%
Short % of float
10.00%
50-day average
10.06
200-day average
10.46

Financials — quick view

All financials
ATEC Revenue — quarterly 221.17M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ATEC Net income — quarterly -5.47M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ATEC EPS — quarterly -0.03
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ATEC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20260.1266———
Oct 29, 2026Sep 30, 20260.095120.09-0.01-5.38%
Aug 4, 2026Jun 30, 20260.069460.070.00+0.78%
May 5, 2026Mar 31, 2026-0.01-0.22-0.21-2,100.00%
Feb 24, 2026Dec 31, 20250.040.06+0.02+50.00%
Oct 30, 2025Sep 30, 2025-0.030.03+0.06+200.00%

Upgrades / downgrades

ATEC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Canaccord GenuitymainBuyBuy
Oct 30, 2026JP MorganmainOverweightOverweight
Oct 30, 2026TD CowenmainBuyBuy
Oct 30, 2026Wells FargomainOverweightOverweight
Oct 30, 2026NeedhammainBuyBuy
Aug 5, 2026UBSmainBuyBuy

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ATEC — it syncs with the Stock Master app.

Insider holders

ATEC insider holders
InsiderRelationLatest transactionDateShares held
BERKOWITZ MORTIMERIIIDirectorStock Award(Grant)Jun 9, 20261,261,160
HUNSAKER CRAIG EOfficerStock GiftMar 8, 20261,725,610
LISH SCOTTChief Operating OfficerSaleMar 12, 2026815,704
MARSHALL TYSON ELIOTGeneral CounselSaleAug 4, 2026630,398
MILES PATRICK SChief Executive OfficerPurchaseSep 9, 20266,154,450
PELIZZON DAVID RDirectorStock Award(Grant)Jun 9, 202610,773,900

Institution ownership

ATEC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.30%11,326,67793.78MJun 29, 2026
Braidwell LP 4.21%6,531,43954.08MJun 29, 2026
American Century Companies Inc4.20%6,521,65954.00MJun 29, 2026
Vanguard Capital Management LLC3.30%5,122,68142.42MJun 29, 2026
BNP Paribas Asset Management Holding S.A.2.28%3,536,53829.28MJun 29, 2026
State Street Corporation2.24%3,481,34928.83MJun 29, 2026

Fund ownership

ATEC fund ownership
Holder% heldSharesValueReported
American Century Mutual Funds, Inc.-Small Cap Growth Fund3.12%4,842,21240.09MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.35%3,649,92530.22MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.06%3,198,45526.48MSep 29, 2026
VANGUARD WHITEHALL FUNDS-Vanguard Mid-Cap Growth Fund1.42%2,196,27418.19MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.87%1,345,30711.14MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.87%1,355,31511.22MAug 30, 2026